Speakers -------- N/A Peptide therapeutics has once again become the focus of innovative drug development. As potential therapeutics, peptides offer several advantages over small molecules (increased specificity) and antibodies (small size). However, delivery and sensitivity to serum and tissue proteases coupled with short serum half-life has remained a major therapeutic stumbling block. Cambridge Healthtech Instituteâ€™s Inaugural Peptide Therapeutics addresses recently developed technologies to overcome these issues thus allowing therapeutic peptides to fulfill their promise as a widely accepted drug class.
|Thursday, January 14, 2010|
|Friday, January 15, 2010|